Ankylosing Spondylitis

Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence
Bon San Koo, Ji Seon Oh, Seo Young Park, Ji Hui Shin, Ga Young Ahn, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim

Annals of the Rheumatic Diseases Oct 2020, 79 (10) 1327-1332; DOI: 10.1136/annrheumdis-2019-216741
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort
Raphael Micheroli, Christoph Tellenbach, Almut Scherer, Kristina Bürki, Karin Niederman, Michael J Nissen, Pascal Zufferey, Pascale Exer, Burkhard Möller, Diego Kyburz, Adrian Ciurea

Annals of the Rheumatic Diseases Sep 2020, 79 (9) 1203-1209; DOI: 10.1136/annrheumdis-2019-215934
Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression
Abdulla Watad, Hannah Rowe, Tobias Russell, Qiao Zhou, Lisa K Anderson, Almas Khan, Robert Dunsmuir, Peter Loughenbury, Vishal Borse, Abhay Rao, Peter A Millner, Nicola Luigi Bragazzi, Howard Amital, Richard Cuhtbert, Miriam Wittmann, Kassem Sharif, Tony Kenna, Matthew A Brown, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1044-1054; DOI: 10.1136/annrheumdis-2020-217309
Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials?
Gareth T Jones, Linda E Dean, Ejaz Pathan, Rosemary J Hollick, Gary J Macfarlane

Annals of the Rheumatic Diseases Jul 2020, 79 (7) 914-919; DOI: 10.1136/annrheumdis-2019-216841
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
Robert BM Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch, Karl Gaffney, Lars Bauer, Bengt Hoepken, Owen R Davies, Natasha de Peyrecave, Karen Thomas, Lianne Gensler

Annals of the Rheumatic Diseases Jul 2020, 79 (7) 920-928; DOI: 10.1136/annrheumdis-2019-216839
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
Désirée van der Heijde, Lianne S Gensler, Atul Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, Mary Katherine Farmer, Dominique Baeten, Nadine Goldammer, Jason Coarse, Marga Oortgiesen, Maxime Dougados

Annals of the Rheumatic Diseases May 2020, 79 (5) 595-604; DOI: 10.1136/annrheumdis-2020-216980
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden
Tine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V Arkema, Rikke Kart Jacobsen, Melinda Magyari, Else Helene Ibfelt, Henning Locht, Finn Sellebjerg, Rene Lindholm Cordtz, Dorte V Jensen, Johan Askling, Lene Dreyer

Annals of the Rheumatic Diseases May 2020, 79 (5) 566-572; DOI: 10.1136/annrheumdis-2019-216693
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, Joachim Sieper, Xenofon Baraliakos, Filip Van den Bosch, Walter P Maksymowych, Joerg Ermann, Jessica A Walsh, Tetsuya Tomita, Atul Deodhar, Désirée van der Heijde, Xiaoqi Li, Fangyi Zhao, Clinton C Bertram, Gaia Gallo, Hilde Carlier, Lianne S Gensler

Annals of the Rheumatic Diseases Feb 2020, 79 (2) 176-185; DOI: 10.1136/annrheumdis-2019-216118
Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years
Xenofon Baraliakos, Adrian Richter, Daniel Feldmann, Anne Ott, Robin Buelow, Carsten O Schmidt, Juergen Braun

Annals of the Rheumatic Diseases Feb 2020, 79 (2) 186-192; DOI: 10.1136/annrheumdis-2019-215553
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis
Uta Kiltz, Robert B M Landewé, Désirée van der Heijde, Martin Rudwaleit, Michael H Weisman, Nurullah Akkoc, Annelies Boonen, Jan Brandt, Philippe Carron, Maxime Dougados, Laure Gossec, Merryn Jongkees, Pedro M Machado, Helena Marzo-Ortega, Anna Molto, Victoria Navarro-Compán, Karin Niederman, Percival Degrava Sampaio-Barros, Gleb Slobodin, Filip E Van den Bosch, Astrid van Tubergen, Salima van Weely, Dieter Wiek, Juergen Braun

Annals of the Rheumatic Diseases Feb 2020, 79 (2) 193-201; DOI: 10.1136/annrheumdis-2019-216034

Main menu

Ankylosing Spondylitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Ankylosing Spondylitis

Pages